An Integrated Digital Strategy: Multi-Channel Healthcare Professional Education Campaign for Dendreon
- Published: Monday, 01 July 2013 12:15
Increase awareness about PROVENGE® (sipuleucel-T) for metastatic, castrate-resistant prostate cancer as an important treatment option which utilizes the patient’s own immune system and extends survival.
Communicate the clinical value and efficacy of PROVENGE to healthcare professionals, including oncologists, hematologists, and urologists.
Click here to read the full case study in PDF format.